Short-term changes in klotho and FGF23 in heart failure with reduced ejection fraction—a substudy of the DAPA-VO(2) study

The klotho and fibroblast growth factor 23 (FGF-23) pathway is implicated in cardiovascular pathophysiology. This substudy aimed to assess the changes in klotho and FGF-23 levels 1-month after dapagliflozin in patients with stable heart failure and reduced ejection fraction (HFrEF). The study includ...

Descripción completa

Detalles Bibliográficos
Autores principales: Mora-Fernández, Carmen, Pérez, Adora, Mollar, Anna, Palau, Patricia, Amiguet, Martina, de la Espriella, Rafael, Sanchis, Juan, Górriz, Jose Luis, Soler, María José, Navarro-González, Juan F., Núñez, Julio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10515719/
https://www.ncbi.nlm.nih.gov/pubmed/37745119
http://dx.doi.org/10.3389/fcvm.2023.1242108

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10515719/
https://www.ncbi.nlm.nih.gov/pubmed/37745119
http://dx.doi.org/10.3389/fcvm.2023.1242108

Ejemplares similares